TY - JOUR
T1 - Efficacy and safety of heat exchanger added to venovenous bypass circuit during orthotopic liver transplantation
AU - Neelakanta, G.
AU - Colquhoun, S.
AU - Csete, M.
AU - Koroleff, D.
AU - Mahajan, A.
AU - Busuttil, R. W.
PY - 1998
Y1 - 1998
N2 - Hypothermia during orthotopic liver transplantation (OLT) is common despite measures to prevent this complication. We retrospectively analyzed two groups of patients; those managed with (n = 113) or without (n = 109) a heat exchanger (HE) incorporated in the venovenous bypass (VVB) circuit to test the hypothesis that normothermia before liver reperfusion minimizes hypotension during reperfusion and decreases neohepatic transfusion requirements. Use of the HE resulted in significantly warmer patients during reperfusion and at the end of surgery (P < .001). An increase in neohepatic transfusion requirement was observed in patients with HE use: packed red- blood cells, 4 ± 4 versus 3 ± 3 units; fresh-frozen plasma, 5 ± 5 versus 4 ± 4 units; platelets, 8 ± 8 versus 6 ± 7 units; and cryoprecipitate, 5 ± 7 versus 3 ± 5 units. There was no difference between the two groups in the untoward hemodynamic events during reperfusion of the liver (P = .31). We conclude that during OLT, the use of an HE in a nonheparinized VVB circuit helps maintain normothermia. Our limited experience suggests that its use is safe but does not improve hemodynamic stability during reperfusion or decrease blood loss during the neohepatic period.
AB - Hypothermia during orthotopic liver transplantation (OLT) is common despite measures to prevent this complication. We retrospectively analyzed two groups of patients; those managed with (n = 113) or without (n = 109) a heat exchanger (HE) incorporated in the venovenous bypass (VVB) circuit to test the hypothesis that normothermia before liver reperfusion minimizes hypotension during reperfusion and decreases neohepatic transfusion requirements. Use of the HE resulted in significantly warmer patients during reperfusion and at the end of surgery (P < .001). An increase in neohepatic transfusion requirement was observed in patients with HE use: packed red- blood cells, 4 ± 4 versus 3 ± 3 units; fresh-frozen plasma, 5 ± 5 versus 4 ± 4 units; platelets, 8 ± 8 versus 6 ± 7 units; and cryoprecipitate, 5 ± 7 versus 3 ± 5 units. There was no difference between the two groups in the untoward hemodynamic events during reperfusion of the liver (P = .31). We conclude that during OLT, the use of an HE in a nonheparinized VVB circuit helps maintain normothermia. Our limited experience suggests that its use is safe but does not improve hemodynamic stability during reperfusion or decrease blood loss during the neohepatic period.
UR - http://www.scopus.com/inward/record.url?scp=0031732628&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031732628&partnerID=8YFLogxK
U2 - 10.1002/lt.500040610
DO - 10.1002/lt.500040610
M3 - Article
C2 - 9791162
AN - SCOPUS:0031732628
VL - 4
SP - 506
EP - 509
JO - Liver Transplantation and Surgery
JF - Liver Transplantation and Surgery
SN - 1074-3022
IS - 6
ER -